BioAge Labs, Inc (BIOA) - Koefisien utang jangka dawa marang modal

BioAge Labs, Inc - logo grafis emiten BIOA

This daily price chart for BioAge Labs, Inc. (BIOA) reflects the dynamics of a company whose developments are being hindered by global conflicts that complicate raw material procurement and international testing. The risks of a Phase II trial failure and pressure from industry behemoths make the dependence on investment critical, with the indicator standing at 0.01. Meanwhile, the business is implementing green IT solutions and strictly adhering to bioethical standards in the creation of anti-aging treatments.

BioAge Labs (BIOA): Utang jangka dawa marang ekuitas saka 27.09.2024 nganti 30.10.2026
Produk mawa merek BioAge Labs, Inc.

The implementation of waste-free synthesis technologies by BioAge Labs, Inc. (BIOA) requires capital expenditures, which is reflected in the structure of long-term liabilities relative to equity. The current value of 0.01 determines the degree of financial leverage and the risk of over-indebtedness, while the long-term financial stability debt indicator on GURU.Markets allows for an assessment of the balance between aggressive growth and the company's safe leverage level.

Analisis perusahaan pesaing

Ascendis Pharma AS - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal MDGL|CORT (Corcept Therapeutics Corp) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal RYTM (Rhythm Pharmaceuticals)|Utang jangka dawa marang modal akerotx.com AKRO|MTSR - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal MLTX (MoonLake Immunotherapeutics AG)|Crinetics Pharma (CRNX) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas NewAmsterdam Pharma Corp|SLNO (Soleno Therapeutics) - Utang jangka dawa marang modal|Utang jangka dawa marang modal amicusrx.com|Rasio utang jangka dawa marang ekuitas ETNB (89bio)|AGIO (Agios) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Structure Pharma GPCR|MDXG - Rasio utang jangka dawa marang ekuitas|Rezolute, Inc. - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal lexpharma.com|MBX (MBX Biosciences) - Rasio utang jangka dawa marang ekuitas|ALT: Rasio silihan jangka dawa marang modal|AARD (Aardvark Therapeutics Corp) - Utang jangka dawa marang modal|Utang jangka dawa marang modal Sagimet Biosciences Inc|Utang jangka dawa marang modal BMEA|Utang jangka dawa marang ekuitas QNCX (quincetx.com)|Utang jangka dawa marang ekuitas Fractyl Health GUTS|vTv Therapeutics, Inc. (VTVT) - Kewajiban jangka dawa marang modal|ATPC - Utang jangka dawa marang ekuitas|PLUR: Utang jangka dawa marang ekuitas|SYBX: Utang jangka dawa marang modal|LPCN - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Matinas BioPharma Holdings, Inc.|Spruce Biosciences Inc. (SPRB) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Galecto Corp (GLTO)|Rasio utang jangka dawa marang ekuitas Carmell Therapeutics CTCX|Utang jangka dawa marang modal LUMO (Lumos Pharma, Inc.)|organovo.com - Utang jangka dawa marang ekuitas|Radius Recycling - Utang jangka dawa marang modal